Twist Bioscience Investor Relations Material
Latest events
Q1 2024
Twist Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Twist Bioscience Corporation
Access all reports
Segment Data
Access more data
Revenue by
Product
NGS tools
Synthetic genes
Antibody discovery
Oligo pools
DNA libraries
Expenses by
Financials
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. It offers synthetic DNA-based tools for research and development applications in life sciences. The company also provides molecular biology solutions comprising molecular cloning, next generation sequencing libraries, protein expression, and gene synthesis solutions; cytometry solutions; and biologics solutions for preclinical study. It serves the biotechnology research, pharmaceuticals and drug discovery, diagnostics, chemical manufacturing, agriculture industries, as well as contract research organizations and academic institutions.
Key slides for Twist Bioscience Corporation
Q1 2024
Twist Bioscience Corporation
Q4 2023
Twist Bioscience Corporation
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States